Unfortunately, there are no data from clinical trials on agents that modify disease complications in people with type 1 diabetes. Should an intervention be of short duration and have long-lasting ...

According to Dr Richa Chaturvedi, senior consultant in endocrinology at Indraprastha Apollo Hospitals, technology is ...

As gestational diabetes becomes more ... of medicine in the division of endocrinology, metabolism, and nutrition at Duke ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...

Following peer review, it will be launched via livestream and published in The Lancet Diabetes & Endocrinology in mid-January 2025 ... The new paper will propose a two-part clinical approach: First, ...

Obesity is a chronic condition and a key risk factor for a range of other health issues, including type 2 diabetes. In a ...

Digital health tools, artificial intelligence (AI), and wearable devices are leading the way in transforming the landscape ...